- $3.77bn
- $4.35bn
- $3.71bn
- 94
- 66
- 77
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,808 | 3,088 | 2,978 | 3,357 | 3,709 |
Cost of Revenue | |||||
Gross Profit | 693 | 785 | 739 | 750 | 840 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,596 | 2,898 | 2,762 | 3,151 | 3,430 |
Operating Profit | 212 | 190 | 216 | 206 | 278 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 182 | 147 | 170 | 174 | 211 |
Provision for Income Taxes | |||||
Net Income After Taxes | 147 | 137 | 143 | 144 | 176 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 160 | 137 | 143 | 144 | 176 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 160 | 137 | 143 | 144 | 176 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.15 | 4.61 | 4.1 | 3.81 | 4.6 |
Dividends per Share |